EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+27.1%
5Y CAGR+32.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+27.1%/yr
vs +46.0%/yr prior
5Y CAGR
+32.9%/yr
Recent deceleration
Acceleration
-18.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $272.74M | +47.1% |
| 2024 | $185.41M | +59.2% |
| 2023 | $116.45M | -12.3% |
| 2022 | $132.72M | +57.9% |
| 2021 | $84.04M | +27.5% |
| 2020 | $65.90M | +0.6% |
| 2019 | $65.54M | +124.2% |
| 2018 | $29.23M | +11.9% |
| 2017 | $26.11M | +11.6% |
| 2016 | $23.39M | - |